JP2009523004A5 - - Google Patents

Download PDF

Info

Publication number
JP2009523004A5
JP2009523004A5 JP2007511043A JP2007511043A JP2009523004A5 JP 2009523004 A5 JP2009523004 A5 JP 2009523004A5 JP 2007511043 A JP2007511043 A JP 2007511043A JP 2007511043 A JP2007511043 A JP 2007511043A JP 2009523004 A5 JP2009523004 A5 JP 2009523004A5
Authority
JP
Japan
Prior art keywords
seq
sequence number
sequence
antibody
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007511043A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009523004A (ja
Filing date
Publication date
Priority claimed from US10/836,956 external-priority patent/US20090215711A1/en
Application filed filed Critical
Publication of JP2009523004A publication Critical patent/JP2009523004A/ja
Publication of JP2009523004A5 publication Critical patent/JP2009523004A5/ja
Pending legal-status Critical Current

Links

JP2007511043A 2004-04-30 2005-05-02 癌における新規の組成物および方法 Pending JP2009523004A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/836,956 US20090215711A1 (en) 2004-04-30 2004-04-30 Novel compositions and methods in cancer
PCT/US2005/014965 WO2005107396A2 (en) 2004-04-30 2005-05-02 Novel compositions and methods in cancer

Publications (2)

Publication Number Publication Date
JP2009523004A JP2009523004A (ja) 2009-06-18
JP2009523004A5 true JP2009523004A5 (enExample) 2009-07-30

Family

ID=35320645

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007511043A Pending JP2009523004A (ja) 2004-04-30 2005-05-02 癌における新規の組成物および方法

Country Status (6)

Country Link
US (2) US20090215711A1 (enExample)
EP (1) EP1747228A4 (enExample)
JP (1) JP2009523004A (enExample)
AU (1) AU2005240070A1 (enExample)
CA (1) CA2563367A1 (enExample)
WO (1) WO2005107396A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1862803A1 (en) * 2006-06-02 2007-12-05 Atlas Antibodies AB Use of protein SATB2 as a marker for colorectal cancer
WO2009063970A1 (ja) 2007-11-14 2009-05-22 Forerunner Pharma Research Co., Ltd. 抗gpr49抗体を用いる癌の診断および治療
EP2172477A1 (en) 2008-10-06 2010-04-07 Atlas Antibodies AB Epitopes derived from SATB2 and uses thereof
KR20110099762A (ko) 2008-12-26 2011-09-08 고쿠리츠다이가쿠호우진 도쿄다이가쿠 항ｌｇｒ７항체를 사용하는 암의 진단 및 치료
US9107892B2 (en) 2010-10-28 2015-08-18 University of Pittsburgh—of the Commonwealth System of Higher Education Identification of a novel retrovirus in patients with benign prostatic hyperplasia
FR2984363B1 (fr) * 2011-12-20 2017-11-24 Biomerieux Sa Procede pour le diagnostic ou le pronostic in vitro du cancer du sein
WO2017062750A1 (en) * 2015-10-09 2017-04-13 The Trustees Of The University Of Pennsylvania Compositions and methods useful in treating stargardt's disease and other ocular disorders
US12577539B2 (en) 2019-04-26 2026-03-17 The Regents Of The University Of California Cells for enhanced production of adeno-associated virus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500938B1 (en) * 1998-01-30 2002-12-31 Incyte Genomics, Inc. Composition for the detection of signaling pathway gene expression
AU2001263408A1 (en) * 2000-05-23 2001-12-03 The Rockefeller University C1 bacteriophage lytic system
WO2002068633A2 (en) * 2000-11-22 2002-09-06 Diadexus, Inc. Compositions and methods relating to lung specific genes and proteins
AUPR201500A0 (en) * 2000-12-11 2001-01-11 Biosceptre Pty Ltd Methods for identifying pre-neoplastic and neoplastic states in mammals
US20030087252A1 (en) * 2000-12-22 2003-05-08 Morris David W. Novel compositions and methods in cancer associated with altered expression of PRDM11
EP1501855A4 (en) * 2002-03-21 2006-02-22 Sagres Discovery Inc NEW COMPOSITIONS AND METHODS FOR CANCER
WO2004016317A1 (en) * 2002-08-14 2004-02-26 Erasmus University Medical Center Rotterdam Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer
US7276596B2 (en) * 2003-02-25 2007-10-02 Pioneer Hi-Bred International, Inc. Promoter from maize invertase inhibitor gene

Similar Documents

Publication Publication Date Title
JP2006518991A5 (enExample)
ES2445892T3 (es) Biomarcadores para el tratamiento anti-TNF en colitis ulcerosa y trastornos relacionados
DK2329259T3 (en) MARKERS AND PROCEDURES FOR ASSESSING AND TREATING ULCERATIVE COLITIS AND RELATED DISEASES USING A 20-GEN PANEL
KR20160138494A (ko) Fgfr 융합물
KR20100131003A (ko) 천식을 치료 및 진단하기 위한 조성물 및 방법
JP2013178260A5 (enExample)
KR20110036610A (ko) 신규 온코진 ｎｒｆ2
JP2008118915A (ja) 胃癌高発現遺伝子特定による胃癌診断および創薬への利用
EP3546943A1 (en) Composition for diagnosis of diseases
KR101515700B1 (ko) Tgfbi를 이용한 패혈증 진단용 조성물 및 이를 이용한 패혈증 예방 또는 치료용 약학적 조성물과 이의 스크리닝 방법
KR20210111176A (ko) 항암제 내성 진단 또는 치료용 조성물
KR102503593B1 (ko) 항암제 내성 진단 또는 치료용 조성물
JP2009523004A5 (enExample)
KR20180109811A (ko) 항암 치료 내성 판단 방법 및 상기 방법에 사용되는 조성물
US20110236396A1 (en) Methods and compositions for diagnosing and treating a colorectal adenocarcinoma
KR102842664B1 (ko) 유전자 발현 검정을 이용한 펩티드 수용체 방사선요법의 예측
KR102574799B1 (ko) 마약 중독 또는 금단증상 진단용 바이오마커 조성물 및 마약 중독 또는 금단증상 진단용 키트
CN105648076B (zh) Nudt11基因及其表达产物作为子宫肌瘤的诊治靶标
WO2022022541A1 (zh) Rbm10基因的用途
CN109536596B (zh) 影响脂肪代谢和儿童生长发育的基因slc22a18
KR102731352B1 (ko) 위암의 예후 예측 방법
CN105838797B (zh) 一种诊治食管癌的分子标志物
CN105331690B (zh) Epb41l4b基因在帕金森病诊治中的应用
CN111630185A (zh) 包含pmvk作为活性成分的用于诊断耐放射癌症或预测放射疗法预后的生物标志物组合物
JP5316749B2 (ja) シスプラチン耐性遺伝子診断方法及びシスプラチン治療効果遺伝子診断キット